Standout Papers

Caspase-3-Generated Fragment of Gelsolin: Effector of Morphological Change in Apoptosis 1997 2026 2006 2016 984
  1. Caspase-3-Generated Fragment of Gelsolin: Effector of Morphological Change in Apoptosis (1997)
    Srinivas Kothakota, Toshifumi Azuma et al. Science
  2. Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology (2013)
    Neal I. Lindeman, Philip T. Cagle et al. Journal of Thoracic Oncology
  3. Mutational Analysis in a Cohort of 224 Tuberous Sclerosis Patients Indicates Increased Severity of TSC2, Compared with TSC1, Disease in Multiple Organs (2001)
    Sandra L. Dabora, Sergiusz Jóźwiak et al. The American Journal of Human Genetics
  4. Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling (2002)
    Andrew R. Tee, Diane C. Fingar et al. Proceedings of the National Academy of Sciences
  5. Reversal of learning deficits in a Tsc2+/− mouse model of tuberous sclerosis (2008)
    Dan Ehninger, Sangyeul Han et al. Nature Medicine
  6. Assessment of Resistance Mechanisms and Clinical Implications in Patients WithEGFRT790M–Positive Lung Cancer and Acquired Resistance to Osimertinib (2018)
    Geoffrey R. Oxnard, Yuebi Hu et al. JAMA Oncology
  7. Akt Stimulates Hepatic SREBP1c and Lipogenesis through Parallel mTORC1-Dependent and Independent Pathways (2011)
    Jessica L. Yecies, Huihui Zhang et al. Cell Metabolism
  8. mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice (2011)
    Ken Inoki, Hiroyuki Mori et al. Journal of Clinical Investigation
  9. Plasma and cytoplasmic gelsolins are encoded by a single gene and contain a duplicated actin-binding domain (1986)
    David J. Kwiatkowski, Thomas P. Stossel et al. Nature

Immediate Impact

11 by Nobel laureates 50 from Science/Nature 236 standout
Sub-graph 1 of 18

Citing Papers

Transferrin receptor targeting chimeras for membrane protein degradation
2024 StandoutNature
DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer
2021 StandoutNature
13 intermediate papers

Works of David J. Kwiatkowski being referenced

FoxOs Enforce a Progression Checkpoint to Constrain mTORC1-Activated Renal Tumorigenesis
2010 Nobel
mTORC1-dependent and -independent regulation of stem cell renewal, differentiation, and mobilization
2008
and 1 more

Author Peers

Author Last Decade Papers Cites
David J. Kwiatkowski 15671 9351 6848 7242 390 32.7k
William C. Hahn 26136 5754 4805 11079 289 40.1k
Joachim Herz 15762 6209 2990 4202 281 35.2k
Chu‐Xia Deng 30697 5201 1965 8816 411 46.4k
Mariano Barbacid 30539 2936 4190 14700 262 51.4k
Joel Moss 12731 6722 3263 6359 631 28.5k
Johannes L. Bos 25358 2366 3074 11047 244 39.3k
M. Celeste Simon 25915 5014 4358 7040 259 46.7k
Hiroyuki Aburatani 23941 1985 5940 8249 525 37.3k
Jerry W. Shay 34712 31580 3464 8781 512 56.7k
Peter M. Lansdorp 14866 13263 2128 3950 265 30.2k

All Works

Loading papers...

Rankless by CCL
2026